Bayer's leadership recognizes AI as a transformative technology across both pharmaceutical development and agricultural applications.

CEO Bill Anderson highlighted AI's significant potential as a tool for accelerating drug development processes at Bayer

The company is actively implementing AI technology in crop protection solutions alongside pharmaceutical research

Bayer is positioning itself to leverage AI across multiple business segments to drive innovation and efficiency